Mark Lloyd
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Osteoarthritis Treatment and Mechanisms
- Orthopedics and Sports Medicine top 10%
- Bone health and osteoporosis research
Papers in
-
- Systemic Lupus Erythematosus Research 6
-
- Inflammatory Myopathies and Dermatomyositis 4
- Acute Ischemic Stroke Management 1
- Co-authors
- Tim D. Spector (4 shared papers)G R Hughes (4 shared papers)Munther A. Khamashta (4 shared papers)Fedza Mujic (4 shared papers)Graham R.V. Hughes (3 shared papers)N K Arden (2 shared papers)María José Cuadrado (2 shared papers)Chris Fife‐Schaw (1 shared paper)
- Journals
- Lara D. Veeken (12 papers)Clinical Medicine (4 papers)The Lancet Rheumatology (2 papers)Journal of Neurology Neurosurgery & Psychiatry (2 papers)Journal of the Royal Society of Medicine (2 papers)
- Partner nations
- United KingdomPortugalSpain
In The Last Decade
Mark Lloyd
42 papers receiving 837 citations
Peers
Comparison fields: 5 of 52
- Rheumatology 231
- Orthopedics and Sports Medicine 36
- Physiology 96
- Public Health, Environmental and Occupational Health 93
- Pulmonary and Respiratory Medicine 78
Countries citing papers authored by Mark Lloyd
This map shows the geographic impact of Mark Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lloyd more than expected).
Fields of papers citing papers by Mark Lloyd
This network shows the impact of papers produced by Mark Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lloyd. The network helps show where Mark Lloyd may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Lloyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 198 | |
| 2 | 2019 | 107 | |
| 3 | 1994 | 67 | |
| 4 | 1996 | 65 | |
| 5 | Immunosuppressive therapy in lupus nephritis. | 1997 | 65 |
| 6 | 2005 | 56 | |
| 7 | Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. | 1995 | 48 |
| 8 | 2000 | 40 | |
| 9 | Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis. | 2014 | 33 |
| 10 | 1994 | 28 | |
| 11 | 1994 | 23 | |
| 12 | Prevalence and clinical significance of subungual splinter haemorrhages in patients with the antiphospholipid syndrome. | 1995 | 18 |
| 13 | 2002 | 18 | |
| 14 | 2021 | 16 | |
| 15 | 2019 | 15 | |
| 16 | 2020 | 14 | |
| 17 | 2024 | 13 | |
| 18 | 1996 | 10 | |
| 19 | 1994 | 9 | |
| 20 | 2022 | 9 |
About Mark Lloyd
Mark Lloyd is a scholar working on Rheumatology, Epidemiology, Endocrinology, Diabetes and Metabolism, Pharmacology and Orthopedics and Sports Medicine, having authored 45 papers that have together received 908 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (6 papers), Inflammatory Myopathies and Dermatomyositis (4 papers), Vasculitis and related conditions (4 papers), Bone health and osteoporosis research (2 papers), Menopause: Health Impacts and Treatments (2 papers), Electronic Health Records Systems (1 paper), Antifungal resistance and susceptibility (1 paper) and Acute Ischemic Stroke Management (1 paper). The work is most often cited by research in Rheumatology (231 citations), Orthopedics and Sports Medicine (36 citations), Physiology (96 citations), Public Health, Environmental and Occupational Health (93 citations) and Pulmonary and Respiratory Medicine (78 citations). Mark Lloyd has collaborated with scholars based in United Kingdom, Portugal and Spain. Frequent co-authors include Tim D. Spector, G R Hughes, Munther A. Khamashta, Fedza Mujic, Graham R.V. Hughes, N K Arden, María José Cuadrado, Chris Fife‐Schaw, David P. D’Cruz and Patrick D W Kiely. Their work appears in journals such as Lara D. Veeken, Clinical Medicine, The Lancet Rheumatology, Journal of Neurology Neurosurgery & Psychiatry and Journal of the Royal Society of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.